Jean-Marc Aiache

Title: Innovations of Jean-Marc Aiache

Introduction

Jean-Marc Aiache is a notable inventor based in Clermont-Ferrand, France. He has made significant contributions to the field of ophthalmic pharmaceuticals, holding a total of 10 patents. His work focuses on developing innovative dosage forms for ocular administration, enhancing the effectiveness of therapeutic systems.

Latest Patents

Among his latest patents is a solid dosage form for the ocular administration of an active principle. This invention includes at least one biocompatible, water-soluble excipient for ophthalmic use. The method of production involves techniques such as direct compression, dry compression, and lyophilization, ensuring that the dosage form can disintegrate and release the active principle effectively in the conjunctival sac. Another significant patent is for prolonged release bioadhesive therapeutic systems. This system contains at least one active principle and is designed to achieve more than 70% dissolution over 8 hours. It comprises natural proteins, hydrophilic polymers, and specific excipients to enhance the local availability of the active principle.

Career Highlights

Jean-Marc Aiache has worked with prominent companies in the pharmaceutical industry, including BioAlliance Pharma and Dow Corning France. His experience in these organizations has contributed to his expertise in developing innovative therapeutic systems.

Collaborations

Throughout his career, Aiache has collaborated with notable professionals in the field, including Dominique Costantini and Christine Chaumont. These collaborations have further enriched his work and contributed to the advancement of ophthalmic therapies.

Conclusion

Jean-Marc Aiache's contributions to the field of ophthalmic pharmaceuticals through his innovative patents and collaborations highlight his significant role as an inventor. His work continues to impact the development of effective therapeutic systems for ocular administration.